Stuart Duty - 16 Oct 2023 Form 3 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
Ron Honig, Attorney-in-Fact for Duty Stuart
Issuer symbol
EYPT
Transactions as of
16 Oct 2023
Net transactions value
$0
Form type
3
Filing time
17 Oct 2023, 16:48:30 UTC
Previous filing
30 Mar 2023
Next filing
09 Jan 2024

No securities are beneficially owned.

Remarks:

No Securities are beneficially owned.